Skip to main content

Advertisement

Table 1 List and information of cases studied

From: Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

Case year Case num Age Sex MMSE PMI APOE NPDx1 NPDx2 Braak tangle stage Braak plaque stage
2003 9 81 M 27 6.4 2/3 N/MBC   II 0
2006 34 79 M N/A 3.52 2/4 N/MBC Other V B
2005 32 89 F 24 3.58 3/3 N/MBC   III B
2004 30 90 F 30 3.8 3/3 N/MBC Other IV B
2005 12 78 M 12 2.8 3/4 N/MBC DLBD III B
2005 13 94 F N/A 5.92   N/MBC   I A
1997 27 66 M N/A 13.37 N/A N/MBC   N/A N/A
1997 32 68 M N/A 2.43 N/A N/MBC   N/A N/A
1999 10 70 M N/A 5.2 N/A N/MBC   N/A N/A
2004 8 75 F N/A 10.5 3/3 N/MBC VD II 0
2003 4 83 M 28 12.4 4/4 N/MBC VD III 0
2002 17 74 M 14 2.6 3/4 N/MBC VD II A
2001 20 85 M 15 3.2 2/4 N/MBC VD III 0
2001 14 73 M N/A 4.3 3/3 N/MBC VD 0 0
2006 1 63 M 10 5.8 3/4 AD   VI C
2006 21 82 M 16 4.7 3/4 AD   VI C
2004 10 71 M 3 6.4 3/3 AD   VI C
2004 44 96 F N/A 4.3 3/4 AD   VI C
2004 46 94 F N/A 26.92 2/3 AD   VI C
2005 31 79 M 6 6 3/4 AD   VI C
2007 15 75 M 18 5.08 3/4 AD   VI C
2008 3 72 M 0 8.25 4/4 AD   VI C
2008 4 68 M 3 4.83 3/4 AD   VI C
2001 12 61 F N/A 2.8 3/4 AD   VI C
2001 18 74 F N/A 4.5 3/4 AD   VI C
  1. AD, Alzheimer’s disease; MMSE, score for the Mini Mental Status Exam; N/A, not available; N/MBC, normal mild Braak changes; NPDx1, neuropathological diagnosis; NPDx2, secondary neuropathological diagnosis; PMI, post mortem interval in hours; VD, vascular dementia.